3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 61.40
-0.20 (-0.32%)
Jun 13, 2025, 1:53 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 4.79 billion as of June 13, 2025. Its market cap has increased by 121.52% in one year.
Market Cap
4.79B
Enterprise Value
4.18B
Revenue
265.69M
Ranking
n/a
PE Ratio
47.38
Stock Price
61.40
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 4.79B, an increase of 75.24%. That is a compound annual growth rate of 13.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 4.79B | -6.55% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 180.96B |
| Caliway Biopharmaceuticals | 149.82B |
| Bora Pharmaceuticals Co., LTD. | 83.79B |
| Lotus Pharmaceutical | 60.82B |
| Polaris Group | 30.66B |
| Center Laboratories | 29.36B |
| Lumosa Therapeutics | 28.02B |
| Oneness Biotech | 27.55B |